(Q44749278)

5 December 2017

title

Identification of HBV DNA sequences that are predictive of response to lamivudine therapy (English)

1 reference

5 December 2017

1 reference

5

John Gerin

1 reference

5 December 2017

2

Antonina Smedile

1 reference

5 December 2017

3

Mario Rizzetto

1 reference

5 December 2017

Alessia Ciancio

1

1 reference

5 December 2017

Marco Lagget

series ordinal

4

1 reference

5 December 2017

Brent Korba

series ordinal

6

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

5 December 2017

1 reference

5 December 2017

volume

39

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

64-73

1 reference

Management of hepatitis B: 2000--summary of a workshop

5 December 2017

cites work

1 reference

7 January 2021

Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine

1 reference

7 January 2021

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

1 reference

7 January 2021

Efficacy of long-term lamivudine monotherapy in patients with hepatitis B e antigen-negative chronic hepatitis B.

1 reference

7 January 2021

Response of pre-core mutant chronic hepatitis B infection to lamivudine

1 reference

7 January 2021

Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver.

1 reference

7 January 2021

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

1 reference

7 January 2021

Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal

1 reference

7 January 2021

Core promoter mutations (A(1762)T and G(1764)A) and viral genotype in chronic hepatitis B and hepatocellular carcinoma in Guangxi, China.

1 reference

7 January 2021

Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy.

1 reference

7 January 2021

Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy

1 reference

7 January 2021

Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.

1 reference

7 January 2021

Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy.

1 reference

7 January 2021

Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B.

1 reference

7 January 2021

Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease

1 reference

7 January 2021

Treatment of HBeAg-negative chronic hepatitis B.

1 reference

7 January 2021

Type D hepatitis: the clinical significance of hepatitis D virus RNA in serum as detected by a hybridization-based assay

1 reference

7 January 2021

Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes

1 reference

7 January 2021

Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region

1 reference

7 January 2021

Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assay

1 reference

7 January 2021

Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene

1 reference

7 January 2021

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

1 reference

7 January 2021

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

1 reference

7 January 2021

Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC (3TC) resistance

1 reference

7 January 2021

Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy

1 reference

7 January 2021

Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection.

1 reference

7 January 2021

Two distinct types of hepatitis B virus core promoter variants in Yemeni blood donors

1 reference

7 January 2021

Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).

1 reference

7 January 2021

Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity

1 reference

7 January 2021

HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20019

1 reference

5 December 2017

1 reference